Cargando…

Successful Treatment of Corticosteroid-Induced Rosacea-Like Dermatitis with Platelet-Rich Plasma Mesotherapy: Report of Seven Cases

INTRODUCTION: Corticosteroid-induced rosacea-like dermatitis (CIRD) is one of the cutaneous side effects of long and excessive application of topical corticosteroids, resembling rosacea that can present with a series of cutaneous manifestations. Most patients with CIRD undergo a variety of long-term...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Xing, Yin, Yue, Dou, Wenjie, Li, Tong, Xue, Ping, Yang, Qing, Ma, Qiaoxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019010/
https://www.ncbi.nlm.nih.gov/pubmed/33539001
http://dx.doi.org/10.1007/s13555-021-00492-1
_version_ 1783674294005399552
author Fan, Xing
Yin, Yue
Dou, Wenjie
Li, Tong
Xue, Ping
Yang, Qing
Ma, Qiaoxin
author_facet Fan, Xing
Yin, Yue
Dou, Wenjie
Li, Tong
Xue, Ping
Yang, Qing
Ma, Qiaoxin
author_sort Fan, Xing
collection PubMed
description INTRODUCTION: Corticosteroid-induced rosacea-like dermatitis (CIRD) is one of the cutaneous side effects of long and excessive application of topical corticosteroids, resembling rosacea that can present with a series of cutaneous manifestations. Most patients with CIRD undergo a variety of long-term treatments before their symptoms are relieved as there is no accepted standard therapy. We gave each of seven patients two sessions of platelet-rich plasma (PRP) mesotherapy before the routine treatment to restore their skin barrier function, and we were surprised to find that the patients’ symptoms and appearance were significantly improved without any further treatments. Here we report this unexpected finding in dealing with CIRD. CASE PRESENTATION: Seven patients, one male and six female, who had history of applying topical corticosteroids on the face for more than 3 months continuously or intermittently for various reasons were diagnosed with CIRD, showing varying degrees of erythema, telangiectasia, and papules, with dry skin, pain, and burning or stinging sensation. We intended to use the restorative effect of PRP to restore the skin barrier function of the patients for further treatment such as tacrolimus ointment, intense pulsed light (IPL), or pulsed dye laser (PDL), so they were treated twice with PRP intradermal injections using a mesogun injector machine. We used the VISIA skin detector to photograph and compare the changes after the treatments. Clinical efficacy was also assessed by the Global Aesthetic Improvement Scale (GAIS). Patients’ assessments were recorded using three-point scale questionnaires. After two sessions of PRP treatment, before any further treatment, we were surprised to find that the patients' symptoms had improved significantly, as confirmed by VISIA skin detector and GAIS. All of the patients were satisfied with the outcomes, considering that mesotherapy was not painful and their appearance and symptoms had much improved. CONCLUSIONS: PRP mesotherapy may mitigate sensitivity and inflammation in patients with CIRD by reducing erythema, telangiectasia, and papules. It is worth conducting large randomized controlled trials to verify its safety and efficacy in treating corticosteroid-induced rosacea-like dermatitis and maybe rosacea.
format Online
Article
Text
id pubmed-8019010
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-80190102021-04-16 Successful Treatment of Corticosteroid-Induced Rosacea-Like Dermatitis with Platelet-Rich Plasma Mesotherapy: Report of Seven Cases Fan, Xing Yin, Yue Dou, Wenjie Li, Tong Xue, Ping Yang, Qing Ma, Qiaoxin Dermatol Ther (Heidelb) Case Report INTRODUCTION: Corticosteroid-induced rosacea-like dermatitis (CIRD) is one of the cutaneous side effects of long and excessive application of topical corticosteroids, resembling rosacea that can present with a series of cutaneous manifestations. Most patients with CIRD undergo a variety of long-term treatments before their symptoms are relieved as there is no accepted standard therapy. We gave each of seven patients two sessions of platelet-rich plasma (PRP) mesotherapy before the routine treatment to restore their skin barrier function, and we were surprised to find that the patients’ symptoms and appearance were significantly improved without any further treatments. Here we report this unexpected finding in dealing with CIRD. CASE PRESENTATION: Seven patients, one male and six female, who had history of applying topical corticosteroids on the face for more than 3 months continuously or intermittently for various reasons were diagnosed with CIRD, showing varying degrees of erythema, telangiectasia, and papules, with dry skin, pain, and burning or stinging sensation. We intended to use the restorative effect of PRP to restore the skin barrier function of the patients for further treatment such as tacrolimus ointment, intense pulsed light (IPL), or pulsed dye laser (PDL), so they were treated twice with PRP intradermal injections using a mesogun injector machine. We used the VISIA skin detector to photograph and compare the changes after the treatments. Clinical efficacy was also assessed by the Global Aesthetic Improvement Scale (GAIS). Patients’ assessments were recorded using three-point scale questionnaires. After two sessions of PRP treatment, before any further treatment, we were surprised to find that the patients' symptoms had improved significantly, as confirmed by VISIA skin detector and GAIS. All of the patients were satisfied with the outcomes, considering that mesotherapy was not painful and their appearance and symptoms had much improved. CONCLUSIONS: PRP mesotherapy may mitigate sensitivity and inflammation in patients with CIRD by reducing erythema, telangiectasia, and papules. It is worth conducting large randomized controlled trials to verify its safety and efficacy in treating corticosteroid-induced rosacea-like dermatitis and maybe rosacea. Springer Healthcare 2021-02-04 /pmc/articles/PMC8019010/ /pubmed/33539001 http://dx.doi.org/10.1007/s13555-021-00492-1 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Case Report
Fan, Xing
Yin, Yue
Dou, Wenjie
Li, Tong
Xue, Ping
Yang, Qing
Ma, Qiaoxin
Successful Treatment of Corticosteroid-Induced Rosacea-Like Dermatitis with Platelet-Rich Plasma Mesotherapy: Report of Seven Cases
title Successful Treatment of Corticosteroid-Induced Rosacea-Like Dermatitis with Platelet-Rich Plasma Mesotherapy: Report of Seven Cases
title_full Successful Treatment of Corticosteroid-Induced Rosacea-Like Dermatitis with Platelet-Rich Plasma Mesotherapy: Report of Seven Cases
title_fullStr Successful Treatment of Corticosteroid-Induced Rosacea-Like Dermatitis with Platelet-Rich Plasma Mesotherapy: Report of Seven Cases
title_full_unstemmed Successful Treatment of Corticosteroid-Induced Rosacea-Like Dermatitis with Platelet-Rich Plasma Mesotherapy: Report of Seven Cases
title_short Successful Treatment of Corticosteroid-Induced Rosacea-Like Dermatitis with Platelet-Rich Plasma Mesotherapy: Report of Seven Cases
title_sort successful treatment of corticosteroid-induced rosacea-like dermatitis with platelet-rich plasma mesotherapy: report of seven cases
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019010/
https://www.ncbi.nlm.nih.gov/pubmed/33539001
http://dx.doi.org/10.1007/s13555-021-00492-1
work_keys_str_mv AT fanxing successfultreatmentofcorticosteroidinducedrosacealikedermatitiswithplateletrichplasmamesotherapyreportofsevencases
AT yinyue successfultreatmentofcorticosteroidinducedrosacealikedermatitiswithplateletrichplasmamesotherapyreportofsevencases
AT douwenjie successfultreatmentofcorticosteroidinducedrosacealikedermatitiswithplateletrichplasmamesotherapyreportofsevencases
AT litong successfultreatmentofcorticosteroidinducedrosacealikedermatitiswithplateletrichplasmamesotherapyreportofsevencases
AT xueping successfultreatmentofcorticosteroidinducedrosacealikedermatitiswithplateletrichplasmamesotherapyreportofsevencases
AT yangqing successfultreatmentofcorticosteroidinducedrosacealikedermatitiswithplateletrichplasmamesotherapyreportofsevencases
AT maqiaoxin successfultreatmentofcorticosteroidinducedrosacealikedermatitiswithplateletrichplasmamesotherapyreportofsevencases